Cytek Biosciences, Inc.
CTKBNASDAQHealthcareMedical Devices
As of Oct 23, 2026 close
- Market cap
- $723.68M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $3.31$6.21
- Volume (live)
- -
- Avg. volume (3M)
- 1.47M
Cytek Biosciences (CTKB) Stock Price & Financial Analysis
Cytek Biosciences Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $5.30 - $5.64 |
|---|---|
| 52-Week High | $6.21 |
| 52-Week Low | $3.31 |
| Open | $5.38 |
| Volume (last close) | 704.86K |
| Average Volume (3M) | 1.47M |
| Revenue (TTM) | 206.71M |
|---|---|
| Net Income (TTM) | -80.58M |
| Free Cash Flow (TTM) | -12.11M |
| EPS (TTM) | −$0.63 |
| Profit Margin | -38.98% |
| Operating Margin | -21.60% |
| Return on Equity (ROE) | -25.03% |
| Debt to Equity | 0.03 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 723.68M |
|---|---|
| Shares Outstanding | 129.46M |
| Price to Sales (P/S) | 3.50 |
| Price to Book (P/B) | 2.25 |
| EV/EBITDA | -20.63 |
| 50-Day MA | $5.10 |
|---|---|
| 200-Day MA | $4.64 |
| 1-Year Change | +30.53% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
Cytek Biosciences at a Glance
As of the Oct 23, 2026 close, Cytek Biosciences (CTKB) has a market capitalization of $723.68M. The stock trades at 3.5× sales. Over the trailing twelve months it lost $80.58M on revenue of $206.71M and burned $12.11M of free cash flow. Revenue grew 5.4% year over year.
As of its latest reported balance sheet, it holds $73.85M in cash and securities against $9.68M of debt, a net cash position of $64.17M.
Cytek Biosciences does not currently pay a dividend.
The share price is up 30.5% over the past year. At $5.59 (the Oct 23, 2026 close) it sits within its 52-week range of $3.31 to $6.21, above its 200-day moving average of $4.64.
Based on 1 professional analyst rating from the past 90 days, the consensus is Hold.
Frequently Asked Questions About Cytek Biosciences
What is the current stock price for CTKB?
As of the Oct 23, 2026 close, CTKB stock trades at $5.59. The 52-week range is $3.31–$6.21, with a day range of $5.30–$5.64.
What is the P/E ratio for CTKB?
The P/E ratio (Price-to-Earnings) for CTKB is shown in the Key Statistics section. This valuation metric helps compare Cytek Biosciences, Inc. to industry peers.
Does CTKB pay dividends?
Cytek Biosciences does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for CTKB?
Based on ratings from 1 professional analyst over the last 90 days, the consensus for CTKB is Hold.
What is the market cap of CTKB?
As of the Oct 23, 2026 close, Cytek Biosciences's market capitalization is $723.7M, classifying it as a small-cap company. Cytek Biosciences operates in the Healthcare sector within the Medical Devices industry.